Company Filing History:
1 out of 2,119 
1 out of 1,308 
1 out of 1,381 
Years Active: 2024
Title: Amisha Wallia: Innovator in Immune Modulation
Introduction
Amisha Wallia is a notable inventor based in Chicago, IL, who has made significant contributions to the field of immune modulation. Her innovative work focuses on the use of vitamin D as a therapeutic agent to combat immune-related complications arising from COVID-19 infections.
Latest Patents
Wallia holds a patent for her groundbreaking invention titled "Vitamin D as an immune modulator to prevent immune-related complications from COVID-19 infection." This patent discloses methods and compositions that are useful in reducing inflammation, enhancing epithelial tissue generation, and lowering mean pulmonary artery pressure in the lungs of affected subjects. The compositions primarily comprise vitamin D, its analogs, or metabolites, and the methods involve administering these compositions to individuals suffering from viral infections, including SARS-CoV-2.
Career Highlights
Throughout her career, Amisha Wallia has worked with prestigious institutions such as Northwestern University and Case Western Reserve University. Her research has focused on the intersection of immunology and infectious diseases, particularly in the context of viral infections.
Collaborations
Wallia has collaborated with esteemed colleagues, including Kurt Q Lu and Livia A Veress, to advance her research and develop innovative solutions in the field of immune modulation.
Conclusion
Amisha Wallia's contributions to the field of immune modulation, particularly through her patent on vitamin D, highlight her role as a leading inventor in addressing critical health challenges. Her work continues to pave the way for new therapeutic approaches in combating viral infections.